Diagnosis and treatment of Gardner syndrome with gastric polyposis: A case report and review of the

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:zhp5211018
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Gardner syndrome (GS) is an autosomal dominant disease characterized by the presence of colonic polyposis, osteoma and soft tissue tumors. It is regarded as a clinical subgroup of familial adenomatous polyposis (FAP) and may present at any age from 2 mo to 70 years with a variety of symptoms, either colonic or extracolonic. We present a case of a 23-year-old female patient with GS who presented with gastric polyposis and was successively treated with restorative proctocolectomy in combination with ileal pouch anal anastomosis (RPC/ IPAA), ileostomy, ileostomy closure operation, snare polypectomy during 8 mo. After operation, the patient took oral traditional Chinese medicine pills made of Fructus mume and Bombyx batryticatu for about 6 mo. The innutrition and anaemia of this patient were gradually improved. Gastroscopy showed that the remnant gastric polypi gradually decreased and finally disappeared 19 mo after the first operation. The patient had 2-3 times of solid stool per day at the time we wrote this paper.
其他文献
期刊
目的 分析探讨在脑胶质瘤患者治疗过程中应用人性化护理模式的临床应用价值.方法 选择本院收治的100例脑胶质瘤患者作为研究对象,将其分为对照组和观察组,对照组采取基础护理
今年6月召开的ADA年会过后,关于文迪雅是否可以增加心血管疾病风险的问题再次被推上各大讲台,这主要缘于ADA会议上RECORD研究和BARI2D结果的发布.其实,关于这两个研究,给我们
东莞市2008年成功建立起了社会基本医疗保险制度,实现了医保体系城乡一体化运行,打破所有制界限(打破用工形式和户籍界限,打破城乡界限和身份障碍),使医疗保险范围覆盖社会所
In order to investigate the role of the expression of the Fas/FasL in peripheral blood lymphocytes (PBLC) and the level of IL-2 in serum of patients with condyl
目的 分析1CU重症监护清醒患者护理中针对性护理的应用效果.方法 本次对象为我院2016年1月-2018年4月ICU重症监护清醒患者74例,实施针对性护理的37例患者作为观察组,实施基础
高危患者长期用药安全有效rn2型糖尿病(T2DM)旁路血管成形血运重建研究(BARI2D)是一项国际多中心研究,入选2368例合并稳定性缺血性心脏病的T2DM患者,旨在评估强化药物治疗与
目的 探讨妇产科门诊个性化的健康教育对妊娠期糖尿病妊娠结局的影响.方法 妊娠期糖尿病患者62例随机分为两组,其中常规组31例行常规化护理,研究组31例行个性化健康教育.结果
近年来,长达5年的大型临床研究证实,对于新诊断或已服用一种降糖药物治疗的2型糖尿病患者,罗格列酮长期控制血糖的能力优于格列本脲和二甲双胍单药治疗,且可使“糖尿病的后备
In order to provide a new method for treating proliferative vitreoretinopathy (PVR), the effects of anti-proliferation and apoptosis induction of inhibitors of